54. Type I cryoglobulinaemia: vascular occlusion and thrombosis
نویسندگان
چکیده
منابع مشابه
I-54: New Models for Human and Mouse Genetic
The possibility to reprogram somatic human cells will greatly and deeply change genetic approach and allow the development of new tools to study genetics diseases. Indeed, our ability to study human genetic diseases suffers from the lack of valid in vitro models. The latter should (i) be originating from human primary cells, (ii) be able to self-renew for a long time and (iii) be able to differ...
متن کاملVascular thrombosis in type II diabetes mellitus.
One prevailing point of view is that many individuals with established type II diabetes have gone through years of impairment of glucose tolerance and hyperinsulinism before the appearance of fasting hyperglycemia (1,2). Peripheral insulin resistance plus a pancreatic p-cell insulin secretory defect presumably wage a battle over the years that results ultimately in clinically apparent type II d...
متن کاملPiatelets and Vascular Occlusion
There is evidence that aspirin is partially effective in the prophylaxis of various vasoocclusive disorders. This article reviews pharmacologic opportunities for improvement over and above the therapeutic effect of aspirin. It is concluded that several rational possibilities merit consideration, in particular, the use of combinations of drugs that affect the thrombotic process at different poin...
متن کاملPlatelets and Vascular Occlusion
Coronary angiography has proved beyond doubt that complete coronary occlusion is the rule in the very early hours of infarction. The 60% to 80% rate of coronary recanalization after thrombolytic therapy has proved that thrombosis is a major component of the occlusion at the time when the procedure is performed a few hours after the onset of symptoms. However, the trigger for coronary thrombosis...
متن کاملPiatelets and Vascular Occlusion
Selective inhibitors of thromboxane synthase have two theoretical advantages over inhibitors of the cyclooxygenase enzyme as potential antithrombotic compounds. First, they do not prevent formation of prostacyclin, a platelet-inhibitory, vasodilator compound, coincident with inhibiting thromboxane biosynthesis. Second, the prostaglandin endoperoxide substrate that accumulates in the platelet in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology Advances in Practice
سال: 2018
ISSN: 2514-1775
DOI: 10.1093/rap/rky034.017